DOCT — Beyond Medical Technologies Cashflow Statement

0.000.00%

Last trade - 00:00

UtilitiesHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Beyond Medical Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	C2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3.21	-5.37	-6.52	-2.91	-1.4
Depreciation
Non-Cash Items	1.16	2.93	4.46	1.38	0.414
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.166	-0.086	0.084	0.132	0.093
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities	-1.86	-2.4	-1.83	-1.4	-0.894
Capital Expenditures	-1.61	-1.18	-0.234	—	—
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-3	3	-0.026	-0.468	0
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities	-4.61	1.82	-0.26	-0.468	0
Financing Cash Flow Items	0	—	—	-0.08	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	4.95	0.281	-0.066	2.67	0
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-1.5	-0.297	-2.16	0.807	-0.894